Aanika Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Aanika Biosciences, Inc. - overview
Established
2018
Location
Brooklyn, NY, US
Primary Industry
Biotechnology
About
Based in New York, US, and founded in 2018 by Ellen Jorgensen, Nirmal Roy, and Vishaal B. Bhuyan, Aanika Biosciences, Inc. , f. k.
a. Carverr, Inc. is a biotechnology company that provides valuable insights about client’s supply chains and help them make better consumption choices. In November 2021, Aanika Biosciences, Inc.
raised USD 12 million in a Series A funding led by Adit Ventures, with participation from Draper & Associates Inc and SOSV. Mr. Vishaal Bhuyan is the CEO of Aanika Biosciences, Inc. The company offers a technological solution that enables farmers to watermark crops with edible food-friendly microbes to track, trace and authenticate the direct source of foodborne illness during the product’s journey through the supply chain to trace the direct source of foodborne illness.
In addition, the company’s solutions include assure quality, limiting recalls, and mining useful data to find the actual happening throughout the client’s supply chain, and couple with a back-end system to give new insights to help reduce costs. Aanika Biosciences, Inc. plans to use its proceeds from Series A funding to scale its food tracing technology platform, advance research, and expand its food safety and manufacturing facility.
Current Investors
SOSV, RebelBio, Draper
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Agribusiness
Website
www.aanikabio.com
Verticals
Agtech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.